We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi to Spend $475 Million to Develop mRNA Vaccines for Infectious Diseases
Sanofi to Spend $475 Million to Develop mRNA Vaccines for Infectious Diseases
Sanofi said it plans to spend more than $475 million annually to develop messenger-RNA (mRNA) vaccines for use against a variety of infectious diseases — and expects to have at least six vaccine candidates within four years.